PDCD1 and non-small cell lung carcinoma: Beyond baseline fibrosis, patients with NSCLC with a smoking history, older age, squamous cell carcinoma subtype, and pre-existing pulmonary diseases, and those using PD-1 inhibitor were more likely to be at risk of CIP.